探索与传染病研究、宿主-病原体生物学及抗感染药物发现相关的疾病导向化合物。利用本页面识别与感染模型、应答通路及转化筛选项目相关的低分子化合物。
传染病
按类别选购
病毒性传染病(DOID:934) viral infectious disease (DOID:934)
368细菌性传染病(DOID:104) bacterial infectious disease (DOID:104)
772真菌感染性疾病(DOID:1564) fungal infectious disease (DOID:1564)
399寄生虫传染病(DOID:1398) parasitic infectious disease (DOID:1398)
1,013产品列表
-
2-[(5R)-4-(2-{3-[(6-methylpyridin-3-yl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid化合物 CID: 72944991Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: R609481查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(5R)-4-(2-{3-[(6-methylpyridin-3-yl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid
- SMILES
- OC(=O)C[C@H]1N(CCNc2c1ccc(n2)C(F)(F)F)C(=O)Cc1cccc(c1)Oc1ccc(nc1)C
- InChIKey
- PPSMYAUEJRADFE-HXUWFJFHSA-N
- InChI
- 1S/C25H23F3N4O4/c1-15-5-6-18(14-30-15)36-17-4-2-3-16(11-17)12-22(33)32-10-9-29-24-19(20(32)13-23(34)35)7-8-21(31-24)25(26,27)28/h2-8,11,14,20H,9-10,12-13H2,1H3,(H,29,31)(H,34,35)/t20-/m1/s1
-
2-[(2R)-1-(3,4-dichlorophenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl]acetamide化合物 CID: 9916412Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: R608661查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(2R)-1-(3,4-dichlorophenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl]acetamide
- SMILES
- O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1
- InChIKey
- HYJYRDCPGUEYND-XMMPIXPASA-N
- InChI
- 显示更多
-
2-[(5R)-4-(2-{3-[(3-methylbutanoyl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid化合物 CID: 91827364Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: R608784查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(5R)-4-(2-{3-[(3-methylbutanoyl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid
- SMILES
- CC(CC(=O)Oc1cccc(c1)CC(=O)N1CCNc2c([C@H]1CC(=O)O)ccc(n2)C(F)(F)F)C
- InChIKey
- CJLZUKCACMUYFP-GOSISDBHSA-N
- InChI
- 1S/C24H26F3N3O5/c1-14(2)10-22(34)35-16-5-3-4-15(11-16)12-20(31)30-9-8-28-23-17(18(30)13-21(32)33)6-7-19(29-23)24(25,26)27/h3-7,11,14,18H,8-10,12-13H2,1-2H3,(H,28,29)(H,32,33)/t18-/m1/s1
-
2-[(2-aminoethyl)(methyl)amino]-N-(7-methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide化合物 CID: 58056092Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: A609438查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(2-aminoethyl)(methyl)amino]-N-(7-methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide
- SMILES
- NCCN(c1ncc2c(n1)c(cs2)C(=O)Nc1cc2cccnc2cc1OC)C
- InChIKey
- BUJSZRICYLPWCM-UHFFFAOYSA-N
- InChI
- 1S/C20H20N6O2S/c1-26(7-5-21)20-23-10-17-18(25-20)13(11-29-17)19(27)24-15-8-12-4-3-6-22-14(12)9-16(15)28-2/h3-4,6,8-11H,5,7,21H2,1-2H3,(H,24,27)
-
2-(2-tert-butylphenoxy)-N-{5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}pyridin-3-amine化合物 CID: 71655433Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: T608164查看产品价格与包装
技术标识符
- IUPAC名称
- 2-(2-tert-butylphenoxy)-N-{5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}pyridin-3-amine
- SMILES
- CC(c1ccccc1Oc1ncccc1Nc1nnc(s1)c1ccc(cc1)C(F)(F)F)(C)C
- InChIKey
- ROIKEXLVELZTIZ-UHFFFAOYSA-N
- InChI
- 1S/C24H21F3N4OS/c1-23(2,3)17-7-4-5-9-19(17)32-20-18(8-6-14-28-20)29-22-31-30-21(33-22)15-10-12-16(13-11-15)24(25,26)27/h4-14H,1-3H3,(H,29,31)
-
2-[(2Z)-2-(1,2-dihydropyrazolo[4,3-b]pyridin-3-ylidene)indol-6-yl]-1-phenylethanone化合物 CID: 136188827Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: Z609262查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(2Z)-2-(1,2-dihydropyrazolo[4,3-b]pyridin-3-ylidene)indol-6-yl]-1-phenylethanone
- SMILES
- O=C(c1ccccc1)Cc1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1nccc2
- InChIKey
- CDVMXMZPDJHSCC-UHFFFAOYSA-N
- InChI
- 1S/C22H16N4O/c27-20(15-5-2-1-3-6-15)12-14-8-9-16-13-19(24-18(16)11-14)22-21-17(25-26-22)7-4-10-23-21/h1-11,13,24H,12H2,(H,25,26)
-
2-(2-cyclopropaneamidopyridin-4-yl)-4-methoxy-N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1,3-thiazole-5-carboxamide化合物 CID: 132427688Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C609061查看产品价格与包装
技术标识符
- IUPAC名称
- 2-(2-cyclopropaneamidopyridin-4-yl)-4-methoxy-N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1,3-thiazole-5-carboxamide
- SMILES
- COc1nc(sc1C(=O)NCCCNc1c2CCCCc2nc2c1cccc2)c1ccnc(c1)NC(=O)C1CC1
- InChIKey
- XYSJVXMQSXKJCN-UHFFFAOYSA-N
- InChI
- 显示更多
-
2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(1-methylimidazol-4-yl)- 7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine化合物 CID: 45275255Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: N608822查看产品价格与包装
技术标识符
- IUPAC名称
- 2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(1-methylimidazol-4-yl)- 7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
- SMILES
- Fc1cnc(nc1)[C@@H](Nc1nc(Nc2ncn(c2)C)c2c(n1)[nH]cc2)C
- InChIKey
- QHXBWJSQXSYAGG-VIFPVBQESA-N
- InChI
- 1S/C16H16FN9/c1-9(13-19-5-10(17)6-20-13)22-16-24-14-11(3-4-18-14)15(25-16)23-12-7-26(2)8-21-12/h3-9H,1-2H3,(H3,18,22,23,24,25)/t9-/m0/s1
-
3-[(3,4-dichlorophenyl)methyl]-4-oxo-6-phenoxyphthalazine-1-carboxylic acid化合物 CID: 163201213Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608634查看产品价格与包装
技术标识符
- SMILES
- Clc1cc(Cn2nc(c3ccc(cc3c2=O)Oc2ccccc2)C(=O)O)ccc1Cl
- InChIKey
- IQKNCBUBONVBNJ-UHFFFAOYSA-N
- InChI
- 1S/C22H14Cl2N2O4/c23-18-9-6-13(10-19(18)24)12-26-21(27)17-11-15(30-14-4-2-1-3-5-14)7-8-16(17)20(25-26)22(28)29/h1-11H,12H2,(H,28,29)
-
3-(3-acetylphenyl)-1-[3-[(2R,4S)-2-[(1S)-1-hydroxypropyl]-4-(phenylmethyl)piperidin-1-yl]propyl]urea化合物 CID: 9868459Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: A608165查看产品价格与包装
技术标识符
- IUPAC名称
- 3-(3-acetylphenyl)-1-[3-[(2R,4S)-2-[(1S)-1-hydroxypropyl]-4-(phenylmethyl)piperidin-1-yl]propyl]urea
- SMILES
- CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O
- InChIKey
- UEKNCACYTQCRSI-RCXJIHSJSA-N
- InChI
- 1S/C27H37N3O3/c1-3-26(32)25-18-22(17-21-9-5-4-6-10-21)13-16-30(25)15-8-14-28-27(33)29-24-12-7-11-23(19-24)20(2)31/h4-7,9-12,19,22,25-26,32H,3,8,13-18H2,1-2H3,(H2,28,29,33)/t22-,25-,26+/m1/s1
-
3-[[4-(5-hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide化合物 CID: 23657507Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: H608970查看产品价格与包装
技术标识符
- IUPAC名称
- 3-[[4-(5-hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide
- SMILES
- Oc1ccc(c(c1)Nc1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
- InChIKey
- LKLIRPMEYRVLFV-UHFFFAOYSA-N
- InChI
- 1S/C17H17N5O3S/c1-11-5-6-13(23)10-15(11)21-16-7-8-19-17(22-16)20-12-3-2-4-14(9-12)26(18,24)25/h2-10,23H,1H3,(H2,18,24,25)(H2,19,20,21,22)
-
3-{[(2,6-dichlorophenyl)methyl]amino}-6,7-dimethoxy-1H,4H-indeno[1,2-c]pyrazol-4-one化合物 CID: 45375987Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609015查看产品价格与包装
技术标识符
- IUPAC名称
- 3-{[(2,6-dichlorophenyl)methyl]amino}-6,7-dimethoxy-1H,4H-indeno[1,2-c]pyrazol-4-one
- SMILES
- COc1cc2c3[nH]nc(c3C(=O)c2cc1OC)NCc1c(Cl)cccc1Cl
- InChIKey
- UUDNGLPFGYJJQX-UHFFFAOYSA-N
- InChI
- 1S/C19H15Cl2N3O3/c1-26-14-6-9-10(7-15(14)27-2)18(25)16-17(9)23-24-19(16)22-8-11-12(20)4-3-5-13(11)21/h3-7H,8H2,1-2H3,(H2,22,23,24)
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
传染病下收录了哪些内容?
该分类汇集了注释到与传染病相关靶点和通路的化合物及工具分子。它是快速圈定研究用化合物集的入口,不构成任何治疗建议。
传染病涵盖哪些内容?
传染病是按疾病分类(DOID)下按疾病注释的分类,汇集了跨多个靶点家族、在该领域有相关报道的化合物。
如何为传染病研究挑选化合物?
针对传染病,建议从靶点或通路假设出发,而非从疾病标签出发,随后核实所报道的活性是否在与您体系相关的模型中测得。在确定化合物集之前,请确认效价、选择性和溶解性。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
如何在传染病下查找特定化合物?
可在传染病中按化合物名称、CAS号或SMILES搜索,也可按对应靶点筛选。未收录的化合物或大包装请联系 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![2-[(5R)-4-(2-{3-[(6-methylpyridin-3-yl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/R/6/R609481.png)
![2-[(2R)-1-(3,4-dichlorophenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl]acetamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/R/6/R608661.png)
![2-[(5R)-4-(2-{3-[(3-methylbutanoyl)oxy]phenyl}acetyl)-8-(trifluoromethyl)-1H,2H,3H,4H,5H-pyrido[2,3-e][1,4]diazepin-5-yl]acetic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/R/6/R608784.png)
![2-[(2-aminoethyl)(methyl)amino]-N-(7-methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/A/6/A609438.png)
![2-(2-tert-butylphenoxy)-N-{5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}pyridin-3-amine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/T/6/T608164.png)
![2-[(2Z)-2-(1,2-dihydropyrazolo[4,3-b]pyridin-3-ylidene)indol-6-yl]-1-phenylethanone](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/Z/6/Z609262.png)
![2-(2-cyclopropaneamidopyridin-4-yl)-4-methoxy-N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1,3-thiazole-5-carboxamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C609061.png)
![2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(1-methylimidazol-4-yl)- 7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/N/6/N608822.png)
![3-[(3,4-dichlorophenyl)methyl]-4-oxo-6-phenoxyphthalazine-1-carboxylic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608634.png)
![3-(3-acetylphenyl)-1-[3-[(2R,4S)-2-[(1S)-1-hydroxypropyl]-4-(phenylmethyl)piperidin-1-yl]propyl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/A/6/A608165.png)
![3-[[4-(5-hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/H/6/H608970.png)
![3-{[(2,6-dichlorophenyl)methyl]amino}-6,7-dimethoxy-1H,4H-indeno[1,2-c]pyrazol-4-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609015.png)
危险品化学品经营许可证(带存储)